451 related articles for article (PubMed ID: 26420253)
1. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum angiopoietin-like protein 2 correlates with the metastatic properties of colorectal cancer: a serum biomarker for early diagnosis and recurrence.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Kawamura M; Kawamoto A; Okugawa Y; Saigusa S; Hiro J; Inoue Y; Mohri Y; Goel A; Kusunoki M
Clin Cancer Res; 2014 Dec; 20(23):6175-86. PubMed ID: 25294915
[TBL] [Abstract][Full Text] [Related]
3. Angiopoietin-Like Protein 2 Acts as a Novel Biomarker for Diagnosis and Prognosis in Patients with Esophageal Cancer.
Ide S; Toiyama Y; Shimura T; Kawamura M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Mohri Y; Kusunoki M
Ann Surg Oncol; 2015 Aug; 22(8):2585-92. PubMed ID: 25564164
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-like Protein 2 as a Predictor of Early Recurrence in Patients After Curative Surgery for Gastric Cancer.
Shimura T; Toiyama Y; Tanaka K; Saigusa S; Kitajima T; Kondo S; Okigami M; Yasuda H; Ohi M; Araki T; Inoue Y; Uchida K; Mohri Y; Kusunoki M
Anticancer Res; 2015 Sep; 35(9):4633-9. PubMed ID: 26254352
[TBL] [Abstract][Full Text] [Related]
5. Angiopoietin-like protein 2 is a potential biomarker for gastric cancer.
Yoshinaga T; Shigemitsu T; Nishimata H; Takei T; Yoshida M
Mol Med Rep; 2015 Apr; 11(4):2653-8. PubMed ID: 25484242
[TBL] [Abstract][Full Text] [Related]
6. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and Prognostic Value of Serum Angiopoietin-Like Protein 2 in Patients with Non-Small Cell Lung Cancer.
Chen Y; Jiang H; Zhu L; Wang P; Liu S; Xiao X; Yu H; Dong W
Clin Lab; 2017 Jan; 63(1):59-65. PubMed ID: 28164488
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the diagnostic and prognostic value of circulating cathepsin S in gastric cancer.
Liu WL; Liu D; Cheng K; Liu YJ; Xing S; Chi PD; Liu XH; Xue N; Lai YZ; Guo L; Zhang G
Oncotarget; 2016 May; 7(19):28124-38. PubMed ID: 27058412
[TBL] [Abstract][Full Text] [Related]
10. The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer.
Xue WJ; Feng Y; Wang F; Li P; Liu YF; Guo YB; Wang ZW; Mao QS
Tumour Biol; 2016 Aug; 37(8):11249-57. PubMed ID: 26945573
[TBL] [Abstract][Full Text] [Related]
11. Serum miR-200c expression level as a prognostic biomarker for gastric cancer.
Zhang HP; Sun FB; Li SJ
Genet Mol Res; 2015 Dec; 14(4):15913-20. PubMed ID: 26662382
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
[TBL] [Abstract][Full Text] [Related]
13. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
[TBL] [Abstract][Full Text] [Related]
14. Serum galectin-3 as a potential marker for gastric cancer.
Cheng D; Liang B; Li Y
Med Sci Monit; 2015 Mar; 21():755-60. PubMed ID: 25765552
[TBL] [Abstract][Full Text] [Related]
15. Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer.
Lim JB; Chung HW
Cytokine; 2015 May; 73(1):16-22. PubMed ID: 25689618
[TBL] [Abstract][Full Text] [Related]
16.
Sheng WZ; Chen YS; Tu CT; He J; Zhang B; Gao WD
World J Gastroenterol; 2016 Dec; 22(47):10364-10370. PubMed ID: 28058016
[TBL] [Abstract][Full Text] [Related]
17. Circulating SHIP2 mRNA as a novel biomarker in the diagnosis and prognosis of gastric cancer.
Xie JF; Xie NS; Tang JH; Gu QP; Luo QT
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5129-5134. PubMed ID: 29228424
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of circulating plasma DNA in gastric cancer.
Fang WL; Lan YT; Huang KH; Liu CA; Hung YP; Lin CH; Jhang FY; Chang SC; Chen MH; Chao Y; Lin WC; Lo SS; Fen-Yau Li A; Wu CW; Chiou SH; Shyr YM
Int J Cancer; 2016 Jun; 138(12):2974-83. PubMed ID: 26815009
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated autoantibody signature for the early detection of gastric cancer.
Zayakin P; Ancāns G; Siliņa K; Meistere I; Kalniņa Z; Andrejeva D; Endzeliņš E; Ivanova L; Pismennaja A; Ruskule A; Doniņa S; Wex T; Malfertheiner P; Leja M; Linē A
Int J Cancer; 2013 Jan; 132(1):137-47. PubMed ID: 22684876
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA HOXA11-AS promotes gastric cancer cell proliferation and invasion
Liu Y; Zhang YM; Ma FB; Pan SR; Liu BZ
World J Gastroenterol; 2019 Jun; 25(22):2763-2775. PubMed ID: 31235999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
